What evaluation is needed and what are the criteria for epilepsy surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Epilepsy Surgery Evaluation and Criteria

Every patient with drug-resistant epilepsy (defined as failure of two adequate trials of appropriately chosen antiseizure medications) should be referred for epilepsy surgery evaluation immediately upon establishing drug-resistance, regardless of age up to 70 years, seizure type, epilepsy duration, or comorbidities—this is the treatment of choice and the only intervention proven to reduce mortality in drug-resistant epilepsy. 1

Primary Referral Criteria

Mandatory Referral Situations

Drug-resistant epilepsy is the core criterion, defined by the ILAE as failure of two tolerated, appropriately chosen ASM schedules (monotherapy or combination) to achieve seizure freedom. 1 Once this threshold is met, refer immediately without delay—do not wait to try additional medications or other therapies first. 1

Refer all patients with drug-resistant epilepsy (≤70 years) regardless of:

  • Epilepsy duration (even if decades long)
  • Sex or socioeconomic status
  • Seizure type or epilepsy syndrome (including epileptic encephalopathies)
  • Localization findings
  • Psychiatric comorbidities (including severe psychiatric disease, PNES, or substance abuse if cooperative with management)
  • Whether they appear suitable for resective surgery—other options like neuromodulation or laser ablation may be offered 1

Special Consideration Referrals

Consider referral for:

  • Patients >70 years with no surgical contraindications 1
  • Seizure-free patients on 1-2 ASMs who have a lesion in non-eloquent cortex (children and adults) 1

Do NOT Delay Referral When:

  • Non-ASM therapies haven't been tried yet
  • Surgery is expected to be only "palliative"
  • Patient had prior epilepsy surgery but continues having drug-resistant seizures
  • ASM failure was due to unacceptable side effects rather than lack of efficacy
  • Patient with previous non-adherence now demonstrates drug-resistance and is cooperative 1
  • Patient is reluctant about surgery but willing to be evaluated or counseled 1

Absolute Contraindication to Referral

Do not refer: Patients with active alcohol/substance abuse who are non-cooperative with management 1

Presurgical Evaluation Components

The evaluation follows a stepwise, multimodal approach to localize the epileptogenic zone and assess surgical safety. 2

Phase 1: Basic Essential Evaluation

Required for all surgical candidates:

  • Detailed seizure history and semiology - Document ictal behaviors, progression, duration, and frequency patterns
  • Long-term video-EEG monitoring - Capture multiple typical seizures to determine seizure onset zone and propagation patterns 2
  • High-resolution MRI (minimum 1.5T for Level 1, 3T for Level 2 care) - Identify structural lesions, subtle cortical dysplasias, hippocampal sclerosis 3
  • Neuropsychological evaluation - Assess baseline cognitive function, predict postoperative deficits, lateralize dysfunction 2

Phase 2: Advanced Evaluation (When Needed)

Deploy when Phase 1 is non-localizing or involves complex cases:

  • Functional imaging:

    • PET scan - Identify hypometabolic zones interictally
    • Ictal/interictal SPECT - Localize seizure onset with blood flow changes 4

  • Advanced MRI techniques:

    • Functional MRI (fMRI) - Map eloquent cortex (language, motor)
    • Diffusion tensor imaging/tractography - Visualize white matter tracts 3

  • Source localization:

    • EEG source imaging
    • Magnetoencephalography (MEG) - Localize interictal and ictal activity 4

  • Functional mapping:

    • Transcranial magnetic stimulation (TMS)
    • Intracarotid amobarbital test (Wada) - Lateralize language and memory 4

Phase 3: Invasive Monitoring (Selected Cases)

When non-invasive evaluation is discordant or involves eloquent cortex:

  • Intracranial EEG monitoring (subdural grids, depth electrodes, stereo-EEG)
  • Intraoperative or extraoperative cortical mapping
  • Requires Level 2 epilepsy center capabilities 3

Level of Care Requirements

Level 1 Centers Can Manage:

  • Age ≥9 years
  • Discrete lesions (including hippocampal sclerosis)
  • Lobectomy/lesionectomy on cerebral convexity, not near eloquent cortex
  • Minimum team: Pediatric epileptologist, pediatric neurosurgeon, pediatric neuroradiologist
  • Minimum technology: Video-EEG, 1.5T MRI 3

Level 2 Centers Required For:

  • All ages including very young children
  • Complex etiologies (tuberous sclerosis, Sturge-Weber, hypothalamic hamartoma)
  • Ill-defined, multilobar, hemispheric, or multifocal lesions
  • Normal MRI cases
  • Foci in/abutting eloquent cortex
  • Expanded team: Large multidisciplinary team including neurophysiology, neuropsychology, anesthesia, neurocritical care, psychiatry
  • Advanced technology: 3T MRI, fMRI, DTI, PET/SPECT, MEG, invasive monitoring capabilities 3

Critical Pitfalls to Avoid

The most common error is delayed referral. The average time from epilepsy onset to surgical evaluation remains approximately 20 years—this delay increases morbidity and mortality unnecessarily. 1 Epilepsy surgery is the only treatment proven to improve survival and reverse excess mortality in drug-resistant epilepsy. 1

Do not assume patients are "not surgical candidates" based on:

  • Bilateral EEG findings
  • Psychiatric comorbidity
  • Multiple failed ASMs
  • Previous failed surgery
  • Patient hesitancy (if willing to be evaluated)

These patients may benefit from neuromodulation, laser ablation, or optimized medical management through specialized evaluation. 1

Concordance among modalities is key to surgical success—no single test is absolute. The hypothesis regarding the epileptogenic zone emerges from synthesizing complementary information across all modalities. 2

References

2
Research

Concept of epilepsy surgery and presurgical evaluation.

Epileptic disorders : international epilepsy journal with videotape, 2015

Related Questions

What antiepileptic drug is recommended as first-line therapy for a young woman of child‑bearing age?
When is it safe for a person with epilepsy to live independently?
In a 40‑year‑old patient with a remote history of childhood epilepsy, whose diagnosis was removed at age 21 after a single seizure and who has been seizure‑free for nearly two decades without antiepileptic medication, is transcranial direct current stimulation (tDCS) permissible?
Can epilepsy cause tremors?
What is the diagnostic approach for epilepsy?
Which laboratory tests should be ordered to evaluate thyroid binding globulin and autoimmune thyroid disease?
What are the current guideline recommendations for prophylaxis of supraventricular tachycardia (SVT) in adults?
Is epilepsy surgery appropriate for a patient with drug‑resistant focal epilepsy who has failed at least two antiseizure medications, continues to have disabling seizures, and has a localized epileptogenic focus confirmed by video‑EEG monitoring and high‑resolution MRI?
In a 64-year-old patient after exploratory laparotomy with bilateral Jackson-Pratt drains producing 60 mL output from each drain over the past 8 hours, is this amount normal and when should the drains be removed?
For a 42-year-old patient with newly identified elevated LDL who is starting cholestyramine (Questran, Questran Light, Prevalite, LoCHOLEST), does he still need to follow a heart‑healthy diet, what laboratory monitoring is required, and how should the medication be taken?
Is subcutaneous insulin effective for rapidly lowering severe hypertriglyceridemia in a diabetic patient with triglycerides around 60 mmol/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.